During pregnancy, trophoblasts invade and transform the maternal spiral arteries that supply blood to the placenta. Recent work has revealed that this process occurs in several stages, and details of the molecular and cellular mechanisms are beginning to emerge, including changes that precede or accompany trophoblastic colonization of the vascular media. Disruption and eventual loss of smooth muscle cells and their associated extracellular matrix are central to physiological transformation. Advances in understanding will lead to the identification of the causative factors involved in failure of remodeling in pathological pregnancies and suggest novel diagnostic and therapeutic avenues.
placental villi and invade the uterine wall (interstitial invasion) or migrate in a retrograde manner through the lumen of the spiral arteries as far as the first third of the myometrium (endovascular invasion). 2, 3 It is the interaction of these 2 distinct trophoblast populations with the spiral arteries that results in specific changes to vessel wall structure. Incomplete remodeling of the spiral arteries is associated with second-trimester miscarriage, 4 preterm labor, 5 and pregnancy complications such as preeclampsia and some cases of fetal growth restriction. 3 These conditions are characterized by shallow trophoblast invasion, a decreased population of invasive trophoblasts, and narrow bore arteries retaining muscular walls, further implicating trophoblast invasion as essential to the remodeling process.
EXTRACELLULAR MATRIX IN THE VASCULATURE
The structure and function of the arterial wall is dependent on its resident cells together with the extracellular matrix (ECM), which provides scaffolding and structural support.The ECM is a complex assembly of macromolecules, each with unique biomechanical properties, that act in combination to confer arteries with mechanical strength, elasticity, resilience, and compressibility. The ECM components found in vessel walls include collagen, glycoproteins, proteoglycans, and elastic fibers, which are synthesized by EC and SMC. Pericytes, the mesenchymallike cells that associate with the walls of small blood R emodeling of the uterine spiral arteries during the first 20 weeks of gestation is crucial for a successful outcome of pregnancy. During this process, narrow, muscular, highly coiled vessels are widened to form high-flow, low-resistance channels that lack vasomotor control. This radical change in vessel architecture involves the loss of endothelial cells (EC) and smooth muscle cells (SMC) and degradation of elastin fibers within the internal elastic lamina and musculoelastic media. Vascular cells are replaced by trophoblasts, derived from the developing placenta, embedded in an amorphous fibrinoid matrix. Little is known about the properties of this material; however, the combination of trophoblasts embedded in fibrinoid allows the spiral arteries to maintain their integrity in the absence of elastic tissue.
The purpose of spiral artery remodeling is to ensure that an adequate volume of blood is directed to the intervillous space at a low enough pressure as not to damage the placental villi.This process is initiated under maternal control prior to trophoblast invasion, 1 but complete physiological transformation requires the mediation of extravillous trophoblasts, which detach from anchoring vessels, also produce ECM components, including basement membrane matrix proteins; proteoglycans such as decorin, biglycan, versican, and aggrecan; fibronectin; and various collagens. [6] [7] [8] [9] 
ECM COMPONENTS
Collagen is one of the major components of resistance arteries, providing physical and tensile strength and limiting vessel distension. There are 42 collagen genes in the human genome encoding 27 collagen types 10 ; types I, III, and V are present in large banded fibrils in the intima, media, and adventitia. Collagen IV forms a scaffold in the basement membrane of EC and SMC. 11 Collagen VI microfibrils are also observed. Collagen VIII, XII, XIV, and XVIII make up less than 10% of the total collagen present. 12 Elastin is the other main constituent of the vascular ECM, conferring support, deformability, and passive recoil.These properties allow arteries to regulate changes in blood pressure, which is essential to maintain a constant blood flow. Mature elastic fibers are practically insoluble and metabolically inert and are composed of a homogenous elastin core that is assembled along a scaffold of parallel microfibrils. Elastin is composed of a polymer of tropoelastin molecules that, in arteries, are mainly synthesized by SMC.The microfibrils are made up of different glycoprotein constituents, including fibrillin-1 and -2, microfibril-associated glycoproteins (MAGP-1 and -2), and latent transforming growth factor-β (TGF-β)-binding proteins. These fibers interact with chondroitin sulphate proteoglycans and proteins localized to the elastinmicrofibril interface or to the cell surface-elastic fiber interface, called elastin microfibril interface-located proteins (EMILIN). EMILIN-1 may play an important role in anchoring cells to elastic lamellae, as elastic fibers in the EMILIN-1 knockout mouse exhibit alterations in structure, leading to loss of connections between the elastic lamellae and vascular cells. 13 Interestingly, EMILIN-1 is expressed by stromal and muscle cells in the uterus, 14 and a gradient of EMILIN-1 expression has been noted in the perivascular region of some transformed spiral arteries. Thus, this molecule may promote haptotactic migration of interstitial trophoblasts.
Other ECM molecules found in the arterial wall include laminin, the most abundant glycoprotein in basement membranes. Laminin acts as a linker, binding to cells, heparan sulphate proteoglycan, and collagen IV. Fibronectin, another multifunctional ECM protein, bridges between cell surface integrins and the ECM, thus mediating cellmatrix adhesion. It is synthesized by fibroblasts, monocytes, SMC, and EC, and it binds to collagen, fibrin, and proteoglycans. Proteoglycans are present within the arterial intima and media and are synthesized by SMC, other mesenchymal cells, and EC in the basement membrane. These are highly dispersed, hydrated molecules, formed from different combinations of core proteins and glycosaminoglycans (GAGs). They possess a net negative charge and mediate selective filtering in the basement membrane. The GAG hyaluronan is found within the intima, where it binds large amounts of water to form a viscous hydrated gel that provides the vessel wall with turgor, resilience, and lubrication. It is synthesized primarily by SMC and serves as a ligand for core proteins and a backbone for large proteoglycan complexes.
ECM BREAKDOWN
Catabolism and reorganization of the ECM is fundamental for successful mural remodeling. Poiseuille's law, which relates laminar flow and vascular resistance to the radius of a vessel, states that a small increase in the diameter of the spiral arteries results in a marked decrease in resistance and/or an increase in blood flow. Alterations in composition or spatial arrangement of matrix components within the arterial wall can affect vessel function, leading to loss of vascular tone and vasomotor control. Thus, the actions of the trophoblast that facilitate vascular cell loss and ECM degradation mediate a decrease in blood pressure and enhanced blood flow within the intervillous space. To invade the walls of the spiral arteries, endovascular trophoblasts must penetrate the endothelial cell layer and traverse the basement membrane. In myometrial vessels, they must then degrade the internal elastic lamina before reaching the underlying medial SMC. In decidual vessels, the internal elastic lamina is absent; however, trophoblasts are still required to break down the elastin fibers that reside between layers of smooth muscle. They may also need to degrade medial proteoglycans including decorin, versican, and perlecan. Interstitial trophoblasts colonizing vessels from the outside must degrade collagen and elastin within the adventitia before reaching the arterial media.
Because of the complex composition of vascular ECM, trophoblasts require a plethora of proteases to invade the vessel wall.These include the matrix metalloproteases (MMPs), a disintegrin and metalloprotease domains (ADAMs), cathepsins, caspases, and serine proteases such as urokinase plasminogen activator (uPA), ch motrypsin, trypsin, and elastase. Endovascular trophoblasts migrating transluminally through the spiral arteries adhere to the endothelium and penetrate the intimal layer via cell-cell junctions. They must then traverse the basement membrane upon which the EC reside. Several different MMPs have been shown to degrade basement membrane matrix components, including MMP-3, MMP-9, MMP-10, and the membrane-type MMPs (MT-MMPs). [15] [16] [17] [18] In addition, MMP-3, MMP-7, 19 the MT-MMPs, 20 and ADAM-10 and -15 21, 22 facilitate the disassembly of contacts at EC-EC junctions; these interactions are key for maintaining intimal integrity in normal vessels, 23, 24 so their breakdown is a prerequisite for trophoblast intravasation. Isolated first-trimester trophoblasts or extravillous trophoblasts in situ are known to produce MMP-1, -2, -9, and -12 and MT1-MMP. [25] [26] [27] [28] [29] The endothelium itself may also control the elastic properties of the arterial wall 30, 31 ; thus, loss of EC or disruption of the intimal layer may contribute to an increase in the diameter of the spiral arteries.
ELASTIC FIBERS
Breakdown of elastin within the internal elastic lamina and the vessel media is crucial to allow expansion and abolish elastic recoil. Catabolism of elastic fibers not only impairs the mechanical performance of the arterial wall but also removes the physical barrier that immobilizes SMC and prevents their migration and proliferation. In mature blood vessels, SMC possess a contractile phenotype and exhibit a very low rate of proliferation and synthetic activity; however, they retain a phenotypic plasticity that allows them to carry out reparative processes after injury. In most vessels, damage to the intima stimulates SMC to adopt a proliferative, synthetic phenotype. If breaks in the internal elastic lamina are present, SMC may migrate into the lumen, leading to proliferation, neointima formation, and arterial narrowing. The interstitial-type ECM components fibronectin and type I, III, and V collagen promote transition of SMC to a synthetic phenotype in vitro, whereas SMC cultured on basement membrane or elastic lamina-type ECM components such as laminin, type IV collagen, elastin, heparin, or heparan sulphate retain a contractile phenotype. 32 Hence, regulated degradation of basement membranes or elastic laminae by invasive trophoblasts may promote dedifferentiation of overlying SMC, either via the release of bioactive ECM fragments or as the underlying interstitial ECM is exposed. There is also evidence that trophoblasts release signals that trigger SMC death. 33, 34 
ELASTIN-DERIVED PEPTIDES
High systolic and pulse pressures caused by advanced age or hypertension have been shown to increase the level of circumferential stress on the walls of arteries and lead to breakdown of elastic fibers. 35 We hypothesize that high pressure in the myometrial spiral arteries, generated by trophoblast plugs in the proximal vessel segments, may contribute to elastin breakdown by creating initial fractures in the internal elastic lamina through which trophoblasts may pass. Many vascular diseases are characterized by breakdown of elastin and release of elastin degradation products termed elastin-derived peptides (EDP), which exhibit a wide range of biological activities and may have an important role to play in the regulation of tissue remodeling. Generation of EDP by macrophage-derived MMP-12 has been shown to be important in the development of a murine model of emphysema. 36 In this system, pulmonary macrophages degrade elastin to generate EDP, which are chemotactic for monocytes.This leads to recruitment of further leukocytes to the lung, release of more EDP, and a gradual worsening of the condition. EDP can also stimulate chemotaxis and chemokinesis of leukocytes into the walls of damaged arteries, where they contribute to matrix breakdown and repair. 37 We hypothesize that EDP generated following trophoblast invasion of the spiral arteries may contribute to the recruitment of leukocytes to the vessel wall.
EDP have also been shown to stimulate quiescent arterial SMC to adopt a more proliferative phenotype. [38] [39] [40] [41] When aortic SMC are cultured with EDP, they upregulate the production of fibronectin, which promotes this phenotypic switch. 42 Furthermore, EDP upregulate MMP expression in a variety of cancer cell lines, including human fibrosarcoma HT-1080 cells and breast and melanoma cell lines, promoting both migration and invasion. [43] [44] [45] As MMPs can themselves cleave elastin, the actions of EDP not only facilitate cell migration and invasion but also establish a positive feedback mechanism by which EDP production is maintained. We have observed that trophoblasts can degrade insoluble elastin fibers in vitro, generating smaller elastin fragments. The intracellular elastase activity of vascular SMC is increased following culture with elastin fragments. Furthermore, MMP activity in SMC is increased upon treatment with trophoblast-conditioned medium, both in vitro and in perfused spiral artery segments (L. K. Harris and J. D.Aplin, unpublished data).These findings suggest that soluble factors produced by trophoblasts and elastin fragments generated following trophoblast invasion, may stimulate elastase production in vascular SMC in vivo.We therefore hypothesize that the actions of invasive trophoblasts potentiate elastin breakdown by SMC during arterial remodeling.
Along with the local generation of EDP in vascular disease, evidence of the breakdown of other ECM constituents can be detected in the plasma following an acute coronary event. Elevated levels of collagen propeptides (PIIINP), 46, 47 and the C-terminal propeptide of procollagen I 46, 48, 49 persist within the circulation for several weeks. Endostatin, derived from the C-terminal fragment of the α1-chain of type XVIII collagen, can be detected in plasma following remodeling events. Endostatin is liberated via cleavage of a protein-sensitive hinge by cathepsin L, matrilysin (MMP-7), and elastase. This molecule has potent antiangiogenic effects and induces growth arrest and apoptosis of endothelial cells. It can also stabilize cellcell and cell-matrix interactions, inhibit MMP-2 activity, and antagonize binding of several vascular endothelial growth factor (VEGF) isoforms to the receptor Flk-1. 50 Local release of endostatin from the vessel wall during spiral artery remodeling may therefore promote EC loss.We hypothesize that markers of matrix breakdown may be evident within the blood during the first 20 weeks of pregnancy, as the spiral arteries are remodeled. It may be interesting to ascertain whether a plasma profile of matrix fragments is evident in pregnant women and whether changes in this profile could be used to identify women with impaired arterial remodeling.
CANDIDATE ELASTASES
Human proteases capable of degrading elastin include MMP-2, MMP-3, MMP-7, MMP-9, MMP-12, MMP-13, 51,52 neutrophil elastase, trypsin, chymotrypsin, 53 and SMC elastase/endogenous vascular elastase, 54 as well as caspase-2, -3, and -7 55 and the cathepsins B, K, L, and S. 56 In the vascular wall, most elastases are secreted from activated SMC, 57 although they are also produced by neutrophils, 58 macrophages, 59 platelets, 60 and EC. 61 Trophoblasts are known to produce several elastases including MMP-2, -7, and -9 and cathepsins B and L. 62, 63 Interestingly, the elastase precursor pro-MMP-2 can be activated by elastin itself. Upon binding to insoluble elastin via its collagenbinding domain, pro-MMP-2 is completely converted into its active form, in the absence of other proteolytic activators. 64 However, in healthy vessels, pro-MMP-2 is constitutively expressed in the arterial wall, and no elastin breakdown is detectable. 12 In common with spiral arteries, studies of human arteries containing atherosclerotic lesions have shown that protease expression is upregulated in vascular SMC during the process of vessel remodeling. SMC-derived cathepsins S and K have been found to localize to breaks in the internal elastic lamina within atherosclerotic lesions, whereas normal vessels show little or no cathepsin expression. 65 Macrophages within atherosclerotic lesions also express proteases, including MMP-14, which colocalizes with MMP-2, MT3-MMP (MMP-16), 66 and neutrophil elastase. 67 As macrophages constitute approximately 20% of the immune cells of the decidua, macrophage-derived proteases may have a role to play in spiral artery remodeling. However, their presence is inversely correlated with successful vessel remodeling, 68 so it is likely that this is not their major role in vivo. Uterine natural killer (NK) cells constitute about 70% of the decidual leukocyte population during the first 20 weeks of gestation, after which time their numbers begin to decline.These cells play an essential role in the initiation of decidual artery remodeling in the mouse 69 ; however, less is known about their role in humans. Uterine NK cells may indirectly modulate matrix breakdown, as it has previously been shown that uNK cell-derived interferon-γ upregulates genes in the decidual stroma that limit trophoblast invasion in mice, 70 and interferon-γ decreases the invasion of human extravillous trophoblast cultures via a reduction in MMP-2 activity. 27 Mast cells are present in low numbers within the placental bed, in association with the spiral arteries, and mast cell chymase can degrade fibronectin 71 and type I procollagen. 72 However, these cells are unlikely to play a significant role in regulating connective tissue homeostasis, as increased numbers of mast cells are associated with abnormal rather than healthy pregnancies. [73] [74] [75] 
GROWTH FACTORS
As well as facilitating transit through the vessel wall, MMPs can also liberate growth factors that are stored in the extracellular matrix, including TGF-β and VEGF. MMP-9 releases VEGF bound to proteoglycans, MMP-2 can release TGF-β bound to the ECM, and MMP-2, -9, -13, and -14 can all activate TGF-β. 17 uPA may also promote growth factor release. 76 The availability of growth factors may enhance the survival of invading trophoblasts; conversely, depletion of such factors may promote apoptosis of SMC. In addition, stimulation of signaling pathways following growth factor release may alter cell behavior in a manner that promotes remodeling.
CONCLUSION
Remodeling of the uterine spiral arteries is a highly complex process, effected in part by trophoblasts and trophoblastderived proteases. To maintain vascular integrity, loss of vascular cells and breakdown of ECM must be carefully coordinated and slowly implemented over the first 20 weeks of gestation. It is clear that other cell types, such as macrophages, uNK cells, and mast cells, are present in the environs of the spiral arteries and have the capacity to degrade ECM. Whether they play a direct role in matrix breakdown is yet to be established. Preliminary results from our laboratory show that spiral artery SMC alter their protease profile in response to trophoblast invasion and free elastin fragments and may contribute to the breakdown of ECM components within the arterial wall. Although much work is needed before a complete picture emerges of the molecular mechanisms of arterial remodeling, avenues for developing diagnostic tests and targets for therapeutic interventions are starting to become evident.
